Hans-Peter Adams
Overview
Explore the profile of Hans-Peter Adams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adams H, Hiemenz M, Hertel K, Fuhlbruck F, Thomas M, Oughton J, et al.
J Mol Diagn
. 2024 Sep;
26(11):1018-1033.
PMID: 39270817
Increased adoption of personalized medicine has brought comprehensive genomic profiling (CGP) to the forefront. However, differences in assay, bioinformatics, and reporting systems and lack of understanding of their complex interplay...
2.
Jiang J, Adams H, Lange M, Siemann S, Feldkamp M, McNamara S, et al.
BMC Cancer
. 2020 Sep;
20(1):885.
PMID: 32933495
Background: Identifying and tracking somatic mutations in cell-free DNA (cfDNA) by next-generation sequencing (NGS) has the potential to transform the clinical management of subjects with advanced non-small cell lung cancer...
3.
Jiang J, Adams H, Yao L, Yaung S, Lal P, Balasubramanyam A, et al.
J Mol Diagn
. 2019 Dec;
22(2):228-235.
PMID: 31837429
Molecular biomarkers hold promise for personalization of cancer treatment. However, a typical tumor biopsy may be difficult to acquire and may not capture genetic variations within or across tumors. Given...
4.
Groene J, Mansmann U, Meister R, Staub E, Roepcke S, Heinze M, et al.
Int J Cancer
. 2006 May;
119(8):1829-36.
PMID: 16721809
UICC stage II and III colorectal cancers (CRC) differ fundamentally in prognosis and therapeutic concepts. To analyze differential gene expression between both stages and to establish a relationship between molecular...
5.
Koziol J, Wagner S, Sobel D, Feng A, Adams H
J Clin Neurosci
. 2005 Oct;
12(8):895-901.
PMID: 16249086
Magnetic resonance imaging (MRI) is the most important paraclinical test in the diagnosis of multiple sclerosis (MS) and for delineating its natural history. We investigate MRIs from a longitudinal study...
6.
du Bois A, Luck H, Meier W, Adams H, Mobus V, Costa S, et al.
J Natl Cancer Inst
. 2003 Sep;
95(17):1320-9.
PMID: 12953086
Background: Despite considerable improvement in the treatment of advanced ovarian cancer, the optimization of efficacy and tolerability remains an important issue. Therefore, we performed a randomized, phase III non-inferiority trial...